MapLight Therapeutics (MPLT) Earnings Date & Reports

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MPLT is expected to report earnings to fall 22.73% to -101 cents per share on December 03

MapLight Therapeutics MPLT Stock Earnings Reports

Q3'26

Est.

$-1.02

Q2'26

Missed

by $0.33

Q1'26

Missed

by $0.42

The last earnings report on August 13 showed earnings per share of -132 cents, missing the estimate of -99 cents. With 207.52K shares outstanding, the current market capitalization sits at 580.77M.

View a ticker or compare two or three

MPLT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for MPLT